Unknown

Dataset Information

The glucosylceramide synthase inhibitor PDMP causes lyso-somal lipid accumulation and mTOR inactivation


ABSTRACT: We investigated subcellular sphingolipid distribution using a functionalized sphingosine analogue (pacSph) by confocal microscopy in control, PDMP and NB-DNJ (Miglustat) treated WT and SGPL1 knock-out cells (experimentA; channel 1: pacSph, channel 2: Lamp1). We studied lysosomal sphingolipid (pacSph) export using pulse-chase experiments in control and PDMP treated SGPL1 knock-out cells (experimentB; channel 1: pacSph, channel 2: Lamp1). We analyzed other lipids such as LBPA (immunofluorescence staining) and cholesterol (filipin staining) at the lysosome in control, PDMP and NB-DNJ (Miglustat) treated WT cells by microscopy (experimentC). We investigated a timeline of lipid accumulating effects arising from PDMP treatment by confocal microscopy. Therefore, we investigated LBPA (immunofluore

ORGANISM(S): Homo sapiens (human)

SUBMITTER: Pia Hartwig 

PROVIDER: S-BIAD144 | bioimages |

REPOSITORIES: bioimages